Development of universal influenza vaccines based on influenza virus M and NP genes. (Q30355116)

20 June 2017

title

Development of universal influenza vaccines based on influenza virus M and NP genes. (English)

1 reference

20 June 2017

1 reference

M Zheng

1

1 reference

20 June 2017

J Luo

series ordinal

2

1 reference

20 June 2017

Z Chen

series ordinal

3

1 reference

20 June 2017

publication date

1 November 2013

1 reference

20 June 2017

1 reference

20 June 2017

volume

42

1 reference

20 June 2017

issue

2

1 reference

20 June 2017

page(s)

251-262

1 reference

Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein

20 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

M2e-based universal influenza A vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Safety and immunogenicity of a recombinant hemagglutinin influenza–flagellin fusion vaccine (VAX125) in healthy young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Efficacious recombinant influenza vaccines produced by high yield bacterial expression: a solution to global pandemic and seasonal needs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Novel generations of influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Protection against multiple influenza A virus subtypes by intranasal administration of recombinant nucleoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Unpacking the incoming influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Induction of T cell response by bluetongue virus core-like particles expressing a T cell epitope of the M1 protein of influenza A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

The immunodominant influenza matrix T cell epitope recognized in human induces influenza protection in HLA-A2/K(b) transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Detection and quantification of CD4(+) T cells with specificity for a new major histocompatibility complex class II-restricted influenza A virus matrix protein epitope in peripheral blood of influenza patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

A human multi-epitope recombinant vaccinia virus as a universal T cell vaccine candidate against influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Cell-mediated protection in influenza infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

CD4+ and CD8+ mediated cellular immune response to recombinant influenza nucleoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Comparing the ability of a series of viral protein-expressing plasmid DNAs to protect against H5N1 influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

A universal influenza A vaccine based on the extracellular domain of the M2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Modified M2 proteins produce heterotypic immunity against influenza A virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

An influenza A vaccine based on tetrameric ectodomain of matrix protein 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Enhancement of mucosal immune response against the M2eHBc+ antigen in mice with the fusion expression products of LTB and M2eHBc+ through mucosal immunization route

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Delivery of woodchuck hepatitis virus-like particle presented influenza M2e by recombinant attenuated Salmonella displaying a delayed lysis phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Induction of protection against divergent H5N1 influenza viruses using a recombinant fusion protein linking influenza M2e to Onchocerca volvulus activation associated protein-1 (ASP-1) adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Purified influenza virus nucleoprotein protects mice from lethal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Robust immunity and heterologous protection against influenza in mice elicited by a novel recombinant NP-M2e fusion protein expressed in E. coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Pandemic preparedness: toward a universal influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Comparison of vaccines for induction of heterosubtypic immunity to influenza A virus: cold-adapted vaccine versus DNA prime-adenovirus boost strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Broad humoral and cellular immunity elicited by a bivalent DNA vaccine encoding HA and NP genes from an H5N1 virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Impact of preexisting adenovirus vector immunity on immunogenicity and protection conferred with an adenovirus-based H5N1 influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Efficacy of parainfluenza virus 5 mutants expressing hemagglutinin from H5N1 influenza A virus in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Towards a universal vaccine for avian influenza: protective efficacy of modified Vaccinia virus Ankara and Adenovirus vaccines expressing conserved influenza antigens in chickens challenged with low pathogenic avian influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Further protection against antigenic drift of influenza virus in a ferret model by DNA vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Intranasal immunization with synthetic recombinant vaccine containing multiple epitopes of influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

A universal influenza A vaccine based on adenovirus expressing matrix-2 ectodomain and nucleoprotein protects mice from lethal challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Intracellular neutralization of virus by immunoglobulin A antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Multiple functions of immunoglobulin A in mucosal defense against viruses: an in vitro measles virus model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Intraepithelial cell neutralization of HIV-1 replication by IgA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Immunoglobulin A antibodies against internal HIV-1 proteins neutralize HIV-1 replication inside epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Immunopotentiation of trivalent influenza vaccine when given with VAX102, a recombinant influenza M2e vaccine fused to the TLR5 ligand flagellin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Safety and immunogenicity of multimeric-001--a novel universal influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Multimeric-001: BiondVax's universal flu vaccine. Interview by Duc Le.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

A T cell-inducing influenza vaccine for the elderly: safety and immunogenicity of MVA-NP+M1 in adults aged over 50 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-013-0546-4

Coadministration of seasonal influenza vaccine and MVA-NP+M1 simultaneously achieves potent humoral and cell-mediated responses

21 January 2018

1 reference

12 December 2020

Pharmaceutical and immunological evaluation of human papillomavirus viruslike particle as an antigen carrier

1 reference

12 December 2020

Acceleration of influenza virus clearance by Th1 cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein.

1 reference

12 December 2020

A novel mammalian cell-culture technique for consistent production of a well-tolerated and immunogenic trivalent subunit influenza vaccine

1 reference

12 December 2020

Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice

1 reference

12 December 2020

Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies

1 reference

12 December 2020

Evolutionary analysis of the influenza A virus M gene with comparison of the M1 and M2 proteins

1 reference

12 December 2020

Transcription-inhibition and RNA-binding domains of influenza A virus matrix protein mapped with anti-idiotypic antibodies and synthetic peptides

1 reference

12 December 2020

Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions

1 reference

12 December 2020

Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin

1 reference

12 December 2020

Stimulation of mucosal and systemic antibody responses against recombinant transferrin-binding protein B of Actinobacillus pleuropneumoniae with chitosan after tracheal administration in piglets

1 reference

12 December 2020

10.1007/S15010-013-0546-4

Identifiers

DOI

1 reference

Dimensions Publication ID

20 June 2017

1034076809

0 references

1 reference